You are here

CRUK Science

Cancer Research Technology is owned by Cancer Research UK, the world's largest charitable funder of cancer research. We provide our partners with access to the cutting-edge work being carried out by over 4000 CRUK funded scientists around the UK.

Here you will find a selection of significant scientific papers published by CRUK funded researchers, an introduction to key investigators and the latest updates from the CRUK Science Blog.

  • SPOTLIGHT ON SCIENCE

    In our Spotlight on Science feature, we interview a leading CRUK funded Principal Investigator about their work and field of oncology research.


    Dr Simon Boulton
    Head of the DNA Damage Response lab at Cancer Research UK’s London Research Institute Clare Hall Laboratory.

    Dr Simon Boulton recently won the prestigious Paul Marks Prize for Cancer Research. The prize recognises a new generation of leaders in cancer research, who are making significant contributions to the understanding of cancer or are improving the treatment of the disease through basic or clinical research.

    Read the interview here


    Professor Eyal Gottlieb
    Group Leader of the Apoptosis and Tumour Metabolism laboratory at the Cancer Research UK Beatson Institute, Glasgow.

    Professor Eyal Gottlieb is an expert in the emerging field of cancer metabolism. He has recently been appointed Director of the new Cancer Metabolism Research Unit, established at the Cancer Research UK Beatson Institute.

    Read the interview here


    Professor Charles Swanton
    Group Leader of the Translational Cancer Therapeutics (TCT) laboratory at the Cancer Research UK London Research Institute.

    In a landmark study, published in the New England Journal of Medicine in March 2012, Swanton's group identified that taking a sample from just one part of a tumour may not give a full picture of its genetic landscape, potentially helping to explain why attempts at using single biopsies to identify biomarkers to which personalised cancer treatments can be targeted have not been more successful. A year on, we ask Professor Swanton about the impact of his findings.

    Read the interview here

  • CRUK STRATEGY

    Cancer Research UK’s new research strategy

    In April 2014 CRUK launched its new research strategy Beating Cancer Sooner:

    This strategy sets out an ambitious agenda and our priorities for the years ahead. Over the last 40 years survival rates in the UK have doubled. Today 1 in 2 people survive their cancer. Our ambition is to accelerate progress and see 3 in 4 people surviving their cancer within the next 20 years. Find out more at: http://bit.ly/1g5E9Nt

    We will continue to support a broad spectrum of research across the pipeline, into all types of cancer, across all age groups, emphasising areas which we believe have significant life-saving potential. We plan to grow our investment substantially, increasing our funding in existing areas, as well as establishing important new areas of research. We will launch six new funding schemes throughout 2014 and 2015 to support world-class research that will enable us to meet our ambitions.

    We believe that increasing interaction between scientific disciplines has the potential to deliver innovation and progress. We will launch a new funding scheme to promote multidisciplinary approaches to research and stimulate collaborations between biomedical research and disciplines such as mathematics, physics and engineering.

    We are confident that through implementing our new strategy, together we can and will transform the outlook for cancer patients. If you have any questions, please contact research.strategy@cancer.org.uk.

    “Our progress is dependent on the outstanding individuals and teams who conduct research across the country. It is their curiosity and passion that will ultimately lead us to the answers we need to beat this disease. Whilst no one underestimates the challenges and barriers we have yet to overcome, there is an overriding believe that the next several years can, and will, transform the outlook for cancer patients.”

    Harpal Kumar, Cancer Research UK Chief Executive

  • CRUK SCIENCE BLOG

    This award-winning blog is co-written by three of Cancer Research UK’s professional science communicators, Henry Scowcroft, Kat Arney and Oliver Childs. It covers the latest cancer research, including that funded by Cancer Research UK, as well as highlighting other relevant material, debunking myths and media scares, and providing links to helpful resources.

    http://scienceblog.cancerresearchuk.org/

SPOTLIGHT ON SCIENCE Open

In our Spotlight on Science feature, we interview a leading CRUK funded Principal Investigator about their work and field of oncology research.


Dr Simon Boulton
Head of the DNA Damage Response lab at Cancer Research UK’s London Research Institute Clare Hall Laboratory.

Dr Simon Boulton recently won the prestigious Paul Marks Prize for Cancer Research. The prize recognises a new generation of leaders in cancer research, who are making significant contributions to the understanding of cancer or are improving the treatment of the disease through basic or clinical research.

Read the interview here


Professor Eyal Gottlieb
Group Leader of the Apoptosis and Tumour Metabolism laboratory at the Cancer Research UK Beatson Institute, Glasgow.

Professor Eyal Gottlieb is an expert in the emerging field of cancer metabolism. He has recently been appointed Director of the new Cancer Metabolism Research Unit, established at the Cancer Research UK Beatson Institute.

Read the interview here


Professor Charles Swanton
Group Leader of the Translational Cancer Therapeutics (TCT) laboratory at the Cancer Research UK London Research Institute.

In a landmark study, published in the New England Journal of Medicine in March 2012, Swanton's group identified that taking a sample from just one part of a tumour may not give a full picture of its genetic landscape, potentially helping to explain why attempts at using single biopsies to identify biomarkers to which personalised cancer treatments can be targeted have not been more successful. A year on, we ask Professor Swanton about the impact of his findings.

Read the interview here

CRUK STRATEGY Open

Cancer Research UK’s new research strategy

In April 2014 CRUK launched its new research strategy Beating Cancer Sooner:

This strategy sets out an ambitious agenda and our priorities for the years ahead. Over the last 40 years survival rates in the UK have doubled. Today 1 in 2 people survive their cancer. Our ambition is to accelerate progress and see 3 in 4 people surviving their cancer within the next 20 years. Find out more at: http://bit.ly/1g5E9Nt

We will continue to support a broad spectrum of research across the pipeline, into all types of cancer, across all age groups, emphasising areas which we believe have significant life-saving potential. We plan to grow our investment substantially, increasing our funding in existing areas, as well as establishing important new areas of research. We will launch six new funding schemes throughout 2014 and 2015 to support world-class research that will enable us to meet our ambitions.

We believe that increasing interaction between scientific disciplines has the potential to deliver innovation and progress. We will launch a new funding scheme to promote multidisciplinary approaches to research and stimulate collaborations between biomedical research and disciplines such as mathematics, physics and engineering.

We are confident that through implementing our new strategy, together we can and will transform the outlook for cancer patients. If you have any questions, please contact research.strategy@cancer.org.uk.

“Our progress is dependent on the outstanding individuals and teams who conduct research across the country. It is their curiosity and passion that will ultimately lead us to the answers we need to beat this disease. Whilst no one underestimates the challenges and barriers we have yet to overcome, there is an overriding believe that the next several years can, and will, transform the outlook for cancer patients.”

Harpal Kumar, Cancer Research UK Chief Executive

CRUK SCIENCE BLOG Open

This award-winning blog is co-written by three of Cancer Research UK’s professional science communicators, Henry Scowcroft, Kat Arney and Oliver Childs. It covers the latest cancer research, including that funded by Cancer Research UK, as well as highlighting other relevant material, debunking myths and media scares, and providing links to helpful resources.

http://scienceblog.cancerresearchuk.org/